The benefits for public health will be between EUR 15 and 34 billion, far exceeding the expected costs, which are in the range of EUR 2.6 to 11 billion.
Kasu inimeste tervisele on suur – rahalises väljenduses 15–34 miljardit eurot; see ületab kaugelt prognoositavaid kulusid, mida on 2,6–11 miljardit eurot.